SGEN

Seagen Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

-57.36

p/bv

16.87

DIVIDEND YIELD

0.00%

SGEN price

Seagen

If you had invested

exposure

years ago

ago, you would now have *

today you would have:

*The amount considers the reinvestment of dividends.

Return on Investment SGEN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

today you would have:

Fundamentals SGEN

Valuation

P/E

-57.36

Sector -3.16

Industry -3.16

P/BV

16.87

Sector 1.80

Industry 1.80

P/Revenue (PSR)

18.71

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -210.13

Industry -210.13

EV/EBIT

Sector -36.38

Industry -36.38

P/EBITDA

-54.11

Sector -19.73

Industry -19.73

P/EBIT

-49.86

Sector -67.09

Industry -67.09

P/Total Assets

11.84

Sector 1.06

Industry 1.06

P/Net Current Assets

Sector -9.56

Industry -9.56

P/Working Capital

Sector -93.54

Industry -93.54

EPS

-3.99

Sector -1.78

Industry -1.78

BVPS

13.56

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

75.40%

Sector 41.27%

Industry 41.27%

EBITDA Margin

-37.97%

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

-34.37%

Sector -35.28%

Industry -35.28%

Net Profit Margins

-32.61%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.18

Sector 0.03

Industry 0.03

Profitability

ROE

-29.42%

Sector -61.33%

Industry -61.33%

ROA

-20.64%

Sector -54.29%

Industry -54.29%

ROIC

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.91

Industry 2.91

Net Debt / EBITDA

Sector -20.88

Industry -20.88

Net Debt / EBIT

Sector -3.40

Industry -3.40

Net Debt / Equity

Sector -34,305.41

Industry -34,305.41

Gross Debt / Equity

Sector -0.81

Industry -0.81

Equity/Assets

0.70

Sector 0.46

Industry 0.46

Liabilities/Assets

0.70

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

7.88%

Sector -

Industry -

5Y Earnings CAGR

2.15%

Sector -

Industry -

Fundamentals SGEN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SGEN Seagen Inc.	$0.00	-	0.00%	-57.36	16.87	-29.42%	-32.61%
PFE Pfizer Inc.	$29.34	29.45%	5.59%	43.90	1.99	4.43%	6.34%
ABBV AbbVie Inc.	$289.47	37.80%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$40.24	-9.17%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$146.62	78.84%	2.26%	151.28	8.26	5.07%	3.64%
AZN AstraZeneca PLC	$185.93	12.89%	1.71%	25.01	5.71	24.18%	18.97%
GILD Gilead Sciences Inc.	$167.61	40.09%	1.94%	45.45	16.08	26.68%	14.89%
BMY Bristol-Myers Squibb Company	$62.45	40.35%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$79.97	-32.35%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$461.90	49.19%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$898.12	39.39%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$104.69	53.28%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,056.55	25.75%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$546.20	30.98%	0.00%	34.82	6.62	20.80%	30.61%
CAH Cardinal Health Inc.	$266.52	36.72%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$903.39	8.53%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$33.09	5.55%	0.00%	12.39	2.25	20.46%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

today you would have:

*This calculation reflects price variation only.

SGEN - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Seagen

Seagen Inc.

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2001

Time since IPO - 25 years

2.092

Employees

Seagen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $43.03 billion, with shareholders equity totaling $2.55 billion.

The company employs approximately 2.092 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Seagen Inc. reported $2.30 billion in revenue, generating net income of $-750.23 million.

Key financial metrics include a P/E ratio of -57.36, a price-to-book (P/B) ratio of 16.87, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SGEN.

Market cap

$43.03 billion

Net worth

$2.55 billion

$2,550,421,000.00

Assets

$3.63 billion

$3,634,261,000.00

Total Shares Outstanding

188.14 million

188,135,000

Average Daily Trading Volume

$1.88 million

$1,875,430.66

Sector

Health Care

Industry

Biotechnology

SGEN

SGEN revenue and profits

Financial Results SGEN

DRAG THE FRAME TO SEE MORE DATA

SGEN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,056.55 23,65% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$266.52 35,89% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

MRK - Merck & Co.

$146.62 75,94% (12M)

P/E

151.28

2.26%

ROE

5.07%

P/BV

8.26

ABBV - AbbVie

$289.47 36,37% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

PFE - Pfizer

$29.34 28,20% (12M)

P/E

43.90

5.59%

ROE

4.43%

P/BV

1.99

AZN - AstraZeneca

$185.93 11,81% (12M)

P/E

25.01

1.71%

ROE

24.18%

P/BV

5.71

BMY - Bristol-Myers Squibb

$62.45 39,87% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,056.55 23,65% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$266.52 35,89% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

MRK - Merck & Co.

$146.62 75,94% (12 M)

P/L

151.28

2.26%

ROE

5.07%

P/VP

8.26

ABBV - AbbVie

$289.47 36,37% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

PFE - Pfizer

$29.34 28,20% (12 M)

P/L

43.90

5.59%

ROE

4.43%

P/VP

1.99

AZN - AstraZeneca

$185.93 11,81% (12 M)

P/L

25.01

1.71%

ROE

24.18%

P/VP

5.71

BMY - Bristol-Myers Squibb

$62.45 39,87% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Seagen (SGEN) today?

The current price of Seagen (SGEN) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Seagen (SGEN) pay dividends?

Seagen (SGEN) did not pay dividends over the past year.

Is Seagen (SGEN) a good investment?

Seagen (SGEN) is currently trading at $0.00 with a P/E ratio of -57.36. This represents a -4,813% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Seagen (SGEN) stock?

You can buy Seagen (SGEN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol SGEN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Seagen (SGEN) yield today?

Over the past month, Seagen (SGEN) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Seagen (SGEN) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SGEN

Seagen Inc.

Asset unavailable for trading

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SGEN

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SGEN WITH OTHER STOCKS

ABOUT Seagen

Seagen Inc.

United States

29 years

2001

2.092

PROFIT X PRICE SGEN

Financial Results SGEN

SGEN cash flow

Asset, Revenue and Profit Growth - SGEN

SGEN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Frequently Asked Questions